skip to main content

UTHR Stock Questions

United Therapeutics stock is quoted on the NASDAQ Global Select Market under the ticker symbol "UTHR". You may purchase shares of United Therapeutics stock through a licensed stockbroker or fianancial advisor.

We do not have access to individual account information. Shareholders with inquiries about share count, address corrections, lost certificates, or changes in registered share ownership should first contact their stockbroker or financial advisor. If additional assistance is needed, shareholders may also contact United Therapeutics' stock transfer agent:

Mailing Address:

Computershare
P.O. Box 43006
Providence, RI 02940-3006

Overnight Correspondence Address:

Computershare
P.O. Box 43006
Providence, RI 02940-3006
Website: www.computershare.com/investor
Tel: +1 (201) 680-6578
Toll Free (USA): 1 (800) 524-4458

United Therapeutics made its initial public offering on June 17, 1999.

Yes. On September 22, 2009, United Therapeutics completed a 100% stock dividend, effecting a two-for-one stock split. For information regarding the stock split, please click here.

Our annual report as well as other periodic financial reports and SEC filings may be viewed or downloaded from this website. Click here for these reports.

No. United Therapeutics has no immediate plans for such a program.

Our transfer agent will perform any necessary replacements. A fee is likely associated with this service.

Mailing Address:

Computershare
P.O. Box 43006
Providence, RI 02940-3006

Overnight Correspondence Address:

Computershare
P.O. Box 43006
Providence, RI 02940-3006
Website: www.computershare.com/investor
Tel: +1 (201) 680-6578
Toll Free (USA): 1 (800) 524-4458

Yes, click here and follow the instructions.

Corporate Governance

United Therapeutics was founded on June 26, 1996 as Lung Rx, Inc. The company changed its name to United Therapeutics Corporation in December 1997.

United Therapeutics follows a calendar fiscal year. Its fiscal year ends each December 31, and the quarters end on March 31, June 30 and September 30.

United Therapeutics does not pay a dividend on stock, and does not foresee doing so in the immediate future.

A listing of United Therapeutics' Board of Directors along with a listing of the company's management can be found here.